JPWO2024111636A5 - - Google Patents
Info
- Publication number
- JPWO2024111636A5 JPWO2024111636A5 JP2024560190A JP2024560190A JPWO2024111636A5 JP WO2024111636 A5 JPWO2024111636 A5 JP WO2024111636A5 JP 2024560190 A JP2024560190 A JP 2024560190A JP 2024560190 A JP2024560190 A JP 2024560190A JP WO2024111636 A5 JPWO2024111636 A5 JP WO2024111636A5
- Authority
- JP
- Japan
- Prior art keywords
- delete
- sialorrhea
- clozapine
- hydrate
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022187772 | 2022-11-24 | ||
| PCT/JP2023/042038 WO2024111636A1 (ja) | 2022-11-24 | 2023-11-22 | クロザピン誘発性流涎症改善剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024111636A1 JPWO2024111636A1 (https=) | 2024-05-30 |
| JPWO2024111636A5 true JPWO2024111636A5 (https=) | 2025-09-08 |
Family
ID=91195719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560190A Pending JPWO2024111636A1 (https=) | 2022-11-24 | 2023-11-22 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4623932A1 (https=) |
| JP (1) | JPWO2024111636A1 (https=) |
| CN (1) | CN120225223A (https=) |
| WO (1) | WO2024111636A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025264845A1 (en) * | 2024-06-18 | 2025-12-26 | Anavex Life Sciences Corp. | Use of anavex3-71 for medical treatments |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1986639A4 (en) * | 2006-02-03 | 2010-04-28 | Avanir Pharmaceuticals | PHARMACEUTICAL COMPOSITIONS OF DEXTROMETHORPHANE AND CHINIDINE FOR THE TREATMENT OF DEPRESSION, FEAR STATES AND NEURODEEGENERATIVE DISEASES |
| PT3061821T (pt) | 2009-07-22 | 2019-09-05 | PureTech Health LLC | Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos |
| CN115245515A (zh) * | 2021-04-27 | 2022-10-28 | 杭州剂泰医药科技有限责任公司 | 一种组合物的医药用途 |
| CN114569742B (zh) * | 2022-05-09 | 2022-07-19 | 北京剂泰医药科技有限公司 | 一种组合物及其制备方法和应用 |
-
2023
- 2023-11-22 EP EP23894640.4A patent/EP4623932A1/en active Pending
- 2023-11-22 WO PCT/JP2023/042038 patent/WO2024111636A1/ja not_active Ceased
- 2023-11-22 CN CN202380080815.2A patent/CN120225223A/zh active Pending
- 2023-11-22 JP JP2024560190A patent/JPWO2024111636A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005524658A5 (https=) | ||
| JP2004519469A5 (https=) | ||
| JP2024516371A5 (https=) | ||
| JP2009545560A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP2009535352A5 (https=) | ||
| JP2008501025A5 (https=) | ||
| HU202102B (en) | Process for producing oral pharmaceutical compositions with controlled release of the active components | |
| JP2007530694A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2009538276A5 (https=) | ||
| JP2000159790A5 (https=) | ||
| JP2020523335A5 (https=) | ||
| JPWO2024111636A5 (https=) | ||
| JP2013502461A5 (https=) | ||
| CN115315423A (zh) | 取代芳基类化合物 | |
| JP2019151627A5 (https=) | ||
| JPWO2024181437A5 (https=) | ||
| JP2018021060A5 (https=) | ||
| JP2008521934A5 (https=) | ||
| CN100418526C (zh) | 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用 | |
| JP2019085364A5 (https=) | ||
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| RU2006122630A (ru) | Композиции, содержащие органические соединения | |
| JP2008503574A5 (https=) |